# CVS HEALTH CORPORATION (CVS) FY2026 Q1 P&L / Income Statement

- Company: CVS HEALTH CORPORATION (CVS)
- Period: 2026-01-01 to 2026-03-31
- Filing: Q1 FY2026 10-Q, filed 2026-05-06, accession number 0000064803-26-000052
- Page: https://plicit.ai/financials/cvs/fy2026-q1-income-statement
- Chart image: https://plicit.ai/charts/cvs-fy2026-q1-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-01-01 through 2026-03-31. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 100,426,000,000 US dollars
- **Total operating costs**: 95,746,000,000 US dollars
- **Operating income**: 4,680,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 742,000,000 US dollars
- **Income before income tax provision**: 3,938,000,000 US dollars
- **Income tax provision**: 981,000,000 US dollars
- **Net income**: 2,957,000,000 US dollars
- **Products**: 62,226,000,000 US dollars
- **Services**: 3,835,000,000 US dollars
- **Premiums**: 33,791,000,000 US dollars
- **Net investment income**: 574,000,000 US dollars
- **Cost of products sold**: 55,444,000,000 US dollars
- **Health care costs**: 29,358,000,000 US dollars
- **Operating expenses**: 10,944,000,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to CVS HEALTH CORPORATION: $2.94 B; to noncontrolling interests: $14.00 M.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/cvs/fy2026-q1-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/cvs-fy2026-q1-revenue-by-business-segment-sankey.png

Income statement for 2026-01-01 through 2026-03-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 100,426,000,000 US dollars
- **Total operating costs**: 95,746,000,000 US dollars
- **Operating income**: 4,680,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 742,000,000 US dollars
- **Income before income tax provision**: 3,938,000,000 US dollars
- **Income tax provision**: 981,000,000 US dollars
- **Net income**: 2,957,000,000 US dollars
- **Health Care Benefits**: 35,971,000,000 US dollars
- **Health Services**: 48,237,000,000 US dollars
- **Pharmacy & Consumer Wellness**: 31,989,000,000 US dollars
- **Cost of products sold**: 55,444,000,000 US dollars
- **Health care costs**: 29,358,000,000 US dollars
- **Operating expenses**: 10,944,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 116,197,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Health Care Benefits**: negative 32,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Health Services**: negative 5,628,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Pharmacy & Consumer Wellness**: negative 10,237,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Corporate/ Other**: 126,000,000 US dollars. Reported reconciliation to consolidated revenue.

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to CVS HEALTH CORPORATION: $2.94 B; to noncontrolling interests: $14.00 M.